Oct 5, 2011
Date: Friday 14th October 2011
Time: Presentation – 4.30pm. Followed by drinks and nibbles
Venue: Reception Lounge, Main entrance of Thomas Building, 3 Symonds Street.
Speaker: Dr Fintan Walton, CEO and founder of PharmaVentures
Title: Pharma Ventured, Pharma Gains
Adapting to the huge changes taking place in pharma and biotech – including deals involving nutrition, orphan drugs, wound care, new technologies and even protection against bioterrorism – PharmaVentures continues to be a world leader in shaping deals and alliances in this sector.
We are delighted to welcome Dr Fintan Walton, CEO and founder of PharmaVentures, as the guest speaker at October’s forum. PharmaVentures has 1000 clients in over 38 countries and has executed over 600 assignments for companies that include the major pharmas and biotechs from Baxter and Boehringer Ingleheim to J&J and Merck to Pfizer, Roche and Sanofi.
PharmaVentures assists corporations, investors and legal practices in all aspects of deal transactions, from strategy formulations to execution. It provides specialist strategic advice, transactional services and vital information to empower business decision makers. PharmaVentures also offers expert M&A and out-licensing services with staff experienced in both the life sciences and investment banking industries.
Fintan will examine the current global pharma environment and the impact this is having on the types of deals that are taking place.
Please join us to discuss with Fintan how the changing global trends in the pharma industry are of significance to New Zealand.
All welcome. RSVPs to Margot Bethell for organizational purposes would be greatly appreciated. Please email email@example.com or phone (09) 373 7599 ext 89625 or 0274 305 758.